

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | positive regulation of gamma-delta T cell activation (GO:0046645) | 5.27464274 |
| 2 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 5.11755715 |
| 3 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 5.04676381 |
| 4 | melanin biosynthetic process (GO:0042438) | 5.02976650 |
| 5 | melanin metabolic process (GO:0006582) | 4.90976469 |
| 6 | antigen processing and presentation of endogenous antigen (GO:0019883) | 4.86800400 |
| 7 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 4.75906162 |
| 8 | T cell migration (GO:0072678) | 4.56518098 |
| 9 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 4.45996151 |
| 10 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 4.30586217 |
| 11 | negative regulation of cell killing (GO:0031342) | 4.30586217 |
| 12 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 4.28654568 |
| 13 | secondary metabolite biosynthetic process (GO:0044550) | 4.26654273 |
| 14 | regulation of B cell receptor signaling pathway (GO:0050855) | 4.24916803 |
| 15 | response to peptidoglycan (GO:0032494) | 3.86233546 |
| 16 | regulation of gamma-delta T cell activation (GO:0046643) | 3.85419524 |
| 17 | mast cell activation (GO:0045576) | 3.64737160 |
| 18 | regulation of gamma-delta T cell differentiation (GO:0045586) | 3.63654367 |
| 19 | immunoglobulin mediated immune response (GO:0016064) | 3.54883983 |
| 20 | negative T cell selection (GO:0043383) | 3.52985749 |
| 21 | regulation of antigen processing and presentation of peptide antigen (GO:0002583) | 3.45913086 |
| 22 | response to type I interferon (GO:0034340) | 3.40959953 |
| 23 | cellular response to interleukin-15 (GO:0071350) | 3.38357174 |
| 24 | B cell receptor signaling pathway (GO:0050853) | 3.37974113 |
| 25 | cellular response to type I interferon (GO:0071357) | 3.37872021 |
| 26 | type I interferon signaling pathway (GO:0060337) | 3.37872021 |
| 27 | thymic T cell selection (GO:0045061) | 3.34259519 |
| 28 | regulation of B cell differentiation (GO:0045577) | 3.31749228 |
| 29 | positive regulation of T cell mediated cytotoxicity (GO:0001916) | 3.30357137 |
| 30 | T cell selection (GO:0045058) | 3.29191410 |
| 31 | positive T cell selection (GO:0043368) | 3.26162381 |
| 32 | positive thymic T cell selection (GO:0045059) | 3.25952069 |
| 33 | regulation of T cell mediated cytotoxicity (GO:0001914) | 3.20784987 |
| 34 | response to interleukin-15 (GO:0070672) | 3.20064201 |
| 35 | regulation of alpha-beta T cell proliferation (GO:0046640) | 3.20049531 |
| 36 | negative regulation of interleukin-12 production (GO:0032695) | 3.19774802 |
| 37 | regulation of interleukin-2 biosynthetic process (GO:0045076) | 3.17337521 |
| 38 | positive regulation of tolerance induction (GO:0002645) | 3.15164206 |
| 39 | negative thymic T cell selection (GO:0045060) | 3.14475833 |
| 40 | positive regulation of granulocyte differentiation (GO:0030854) | 3.12065136 |
| 41 | positive regulation of interleukin-2 production (GO:0032743) | 3.11994671 |
| 42 | positive regulation of B cell differentiation (GO:0045579) | 3.11240557 |
| 43 | positive regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043372) | 3.08351315 |
| 44 | regulation of regulatory T cell differentiation (GO:0045589) | 3.07965234 |
| 45 | interferon-gamma-mediated signaling pathway (GO:0060333) | 3.05866282 |
| 46 | regulation of T cell tolerance induction (GO:0002664) | 3.03591848 |
| 47 | cellular response to zinc ion (GO:0071294) | 3.03234769 |
| 48 | B cell mediated immunity (GO:0019724) | 3.03221487 |
| 49 | negative regulation of T cell apoptotic process (GO:0070233) | 3.02622161 |
| 50 | positive regulation by symbiont of host defense response (GO:0052509) | 3.01900091 |
| 51 | modulation by symbiont of host defense response (GO:0052031) | 3.01900091 |
| 52 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 3.01900091 |
| 53 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 3.01900091 |
| 54 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 3.01900091 |
| 55 | modulation by symbiont of host immune response (GO:0052553) | 3.01900091 |
| 56 | regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043370) | 3.00482544 |
| 57 | detection of other organism (GO:0098543) | 2.98273671 |
| 58 | positive regulation of alpha-beta T cell proliferation (GO:0046641) | 2.97627950 |
| 59 | antigen receptor-mediated signaling pathway (GO:0050851) | 2.97547635 |
| 60 | antigen processing and presentation via MHC class Ib (GO:0002475) | 2.96555248 |
| 61 | regulation of antigen processing and presentation (GO:0002577) | 2.96392405 |
| 62 | neutrophil activation involved in immune response (GO:0002283) | 2.95367561 |
| 63 | defense response to protozoan (GO:0042832) | 2.94913142 |
| 64 | interferon-gamma production (GO:0032609) | 2.94440630 |
| 65 | regulation of CD4-positive, alpha-beta T cell activation (GO:2000514) | 2.93951899 |
| 66 | leukocyte aggregation (GO:0070486) | 2.93775578 |
| 67 | response to interferon-alpha (GO:0035455) | 2.93327431 |
| 68 | microglial cell activation (GO:0001774) | 2.93030977 |
| 69 | regulation of tolerance induction (GO:0002643) | 2.92367377 |
| 70 | detection of bacterium (GO:0016045) | 2.92318983 |
| 71 | NIK/NF-kappaB signaling (GO:0038061) | 2.89251832 |
| 72 | lymphocyte migration (GO:0072676) | 2.88730397 |
| 73 | negative regulation of execution phase of apoptosis (GO:1900118) | 2.88695354 |
| 74 | leukocyte degranulation (GO:0043299) | 2.86933954 |
| 75 | T cell receptor signaling pathway (GO:0050852) | 2.86904340 |
| 76 | mast cell activation involved in immune response (GO:0002279) | 2.86597671 |
| 77 | mast cell degranulation (GO:0043303) | 2.86597671 |
| 78 | positive regulation of CD4-positive, alpha-beta T cell activation (GO:2000516) | 2.86513180 |
| 79 | DNA deamination (GO:0045006) | 2.83142435 |
| 80 | response to interferon-beta (GO:0035456) | 2.82668250 |
| 81 | regulation of interferon-beta biosynthetic process (GO:0045357) | 2.79563878 |
| 82 | regulation of humoral immune response mediated by circulating immunoglobulin (GO:0002923) | 2.79494214 |
| 83 | lymphocyte chemotaxis (GO:0048247) | 2.79438774 |
| 84 | tolerance induction (GO:0002507) | 2.75480113 |
| 85 | regulation of mast cell degranulation (GO:0043304) | 2.73520180 |
| 86 | macrophage activation involved in immune response (GO:0002281) | 2.73477104 |
| 87 | negative regulation of interleukin-1 beta production (GO:0032691) | 2.72966706 |
| 88 | myeloid cell activation involved in immune response (GO:0002275) | 2.71112516 |
| 89 | regulation of alpha-beta T cell activation (GO:0046634) | 2.69500816 |
| 90 | negative regulation of lymphocyte mediated immunity (GO:0002707) | 2.69393595 |
| 91 | negative regulation of T cell mediated immunity (GO:0002710) | 2.67574989 |
| 92 | response to protozoan (GO:0001562) | 2.66500343 |
| 93 | positive regulation of antigen processing and presentation (GO:0002579) | 2.65793048 |
| 94 | regulation of antigen receptor-mediated signaling pathway (GO:0050854) | 2.64288145 |
| 95 | cytokine biosynthetic process (GO:0042089) | 2.63548593 |
| 96 | positive regulation of T cell mediated immunity (GO:0002711) | 2.61705705 |
| 97 | negative regulation of interleukin-1 production (GO:0032692) | 2.60201686 |
| 98 | positive regulation of defense response to virus by host (GO:0002230) | 2.58844472 |
| 99 | regulation of autophagic vacuole assembly (GO:2000785) | 2.58272128 |
| 100 | negative regulation of innate immune response (GO:0045824) | 2.58163604 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 6.57379784 |
| 2 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 4.59691284 |
| 3 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 4.38704049 |
| 4 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 4.26745239 |
| 5 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 3.96354580 |
| 6 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 3.38651476 |
| 7 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 3.37814239 |
| 8 | MYB_26560356_Chip-Seq_TH2_Human | 2.80247705 |
| 9 | RUNX_20019798_ChIP-Seq_JUKART_Human | 2.73734152 |
| 10 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 2.70668252 |
| 11 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 2.69671785 |
| 12 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 2.66104246 |
| 13 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 2.53203361 |
| 14 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 2.47335716 |
| 15 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 2.46991312 |
| 16 | SPI1_23547873_ChIP-Seq_NB4_Human | 2.38299854 |
| 17 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 2.37736964 |
| 18 | MYB_26560356_Chip-Seq_TH1_Human | 2.34912210 |
| 19 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 2.29450959 |
| 20 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.23046817 |
| 21 | MAF_26560356_Chip-Seq_TH1_Human | 2.08228913 |
| 22 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 2.06085718 |
| 23 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 2.05719841 |
| 24 | GATA3_27048872_Chip-Seq_THYMUS_Human | 2.02381918 |
| 25 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.96525833 |
| 26 | GATA3_26560356_Chip-Seq_TH2_Human | 1.95392503 |
| 27 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.88506681 |
| 28 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 1.88176001 |
| 29 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.85046126 |
| 30 | UTX_26944678_Chip-Seq_JUKART_Human | 1.78286529 |
| 31 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.76832000 |
| 32 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.76513691 |
| 33 | SPI1_23127762_ChIP-Seq_K562_Human | 1.75529670 |
| 34 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.72875163 |
| 35 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.70173858 |
| 36 | MAF_26560356_Chip-Seq_TH2_Human | 1.68031983 |
| 37 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.66315730 |
| 38 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.66308862 |
| 39 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.66275195 |
| 40 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.62156768 |
| 41 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.56431640 |
| 42 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.52551342 |
| 43 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.45702812 |
| 44 | KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 1.38792733 |
| 45 | VDR_20736230_ChIP-Seq_LYMPHOBLASTOID_Human | 1.38641457 |
| 46 | VDR_23849224_ChIP-Seq_CD4+_Human | 1.36326129 |
| 47 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.36023656 |
| 48 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.32773644 |
| 49 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.31812590 |
| 50 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 1.30341847 |
| 51 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.26766937 |
| 52 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.23830182 |
| 53 | CIITA_25753668_ChIP-Seq_RAJI_Human | 1.23680318 |
| 54 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.22684577 |
| 55 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.22315055 |
| 56 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 1.21743428 |
| 57 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.11616821 |
| 58 | MYC_22102868_ChIP-Seq_BL_Human | 1.10773745 |
| 59 | VDR_21846776_ChIP-Seq_THP-1_Human | 1.10697139 |
| 60 | EBNA2_21746931_ChIP-Seq_IB4-LCL_Human | 1.10293440 |
| 61 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.10042729 |
| 62 | BCL6_27268052_Chip-Seq_Bcells_Human | 1.09625973 |
| 63 | FOXP3_21729870_ChIP-Seq_TREG_Human | 1.09361841 |
| 64 | STAT1_20625510_ChIP-Seq_HELA_Human | 1.08213036 |
| 65 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.05980955 |
| 66 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.05314468 |
| 67 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.01976429 |
| 68 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 1.01252775 |
| 69 | TAL1_22897851_ChIP-Seq_JUKARTE6-1_Human | 1.00816623 |
| 70 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.00216154 |
| 71 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 0.99521149 |
| 72 | NANOG_20526341_ChIP-Seq_ESCs_Human | 0.98089190 |
| 73 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 0.97785055 |
| 74 | FLI1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.97369186 |
| 75 | GATA1_22025678_ChIP-Seq_K562_Human | 0.97187499 |
| 76 | IGF1R_20145208_ChIP-Seq_DFB_Human | 0.96668647 |
| 77 | RBPJ_21746931_ChIP-Seq_IB4-LCL_Human | 0.95920333 |
| 78 | GATA3_26560356_Chip-Seq_TH1_Human | 0.95831715 |
| 79 | P300_27268052_Chip-Seq_Bcells_Human | 0.94966523 |
| 80 | GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.94379385 |
| 81 | SRF_21415370_ChIP-Seq_HL-1_Mouse | 0.93079139 |
| 82 | CTNNB1_20615089_ChIP-ChIP_FETAL_BRAIN_Human | 0.92963298 |
| 83 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.92831373 |
| 84 | SPI1_20517297_ChIP-Seq_HL60_Human | 0.92697642 |
| 85 | CHD7_19251738_ChIP-ChIP_MESCs_Mouse | 0.92024110 |
| 86 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 0.90475594 |
| 87 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 0.90461947 |
| 88 | BCOR_27268052_Chip-Seq_Bcells_Human | 0.90407481 |
| 89 | EST1_17652178_ChIP-ChIP_JURKAT_Human | 0.89952832 |
| 90 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.89161233 |
| 91 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 0.87756049 |
| 92 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.87515245 |
| 93 | HOXA2_22223247_ChIP-Seq_E11.5_EMBRYO_Mouse | 0.86772480 |
| 94 | HOXB4_20404135_ChIP-ChIP_EML_Mouse | 0.86281543 |
| 95 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.85669454 |
| 96 | GRHL2_25758223_ChIP-Seq_PLACENTA_Mouse | 0.85658819 |
| 97 | PU_27001747_Chip-Seq_BMDM_Mouse | 0.85656915 |
| 98 | TFEB_21752829_ChIP-Seq_HELA_Human | 0.85498873 |
| 99 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.83488473 |
| 100 | SMRT_27268052_Chip-Seq_Bcells_Human | 0.83001439 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0003806_abnormal_nucleotide_metabolis | 4.09247865 |
| 2 | MP0001835_abnormal_antigen_presentation | 3.82518087 |
| 3 | MP0005075_abnormal_melanosome_morpholog | 3.82422847 |
| 4 | MP0000372_irregular_coat_pigmentation | 3.76596827 |
| 5 | MP0005671_abnormal_response_to | 3.61372891 |
| 6 | MP0003724_increased_susceptibility_to | 3.33343216 |
| 7 | MP0004381_abnormal_hair_follicle | 3.05997963 |
| 8 | MP0005387_immune_system_phenotype | 2.91591564 |
| 9 | MP0001790_abnormal_immune_system | 2.91591564 |
| 10 | MP0009785_altered_susceptibility_to | 2.88223540 |
| 11 | MP0003763_abnormal_thymus_physiology | 2.80687623 |
| 12 | MP0001800_abnormal_humoral_immune | 2.73184307 |
| 13 | MP0003436_decreased_susceptibility_to | 2.67938282 |
| 14 | MP0005000_abnormal_immune_tolerance | 2.52006916 |
| 15 | MP0000685_abnormal_immune_system | 2.38967933 |
| 16 | MP0002148_abnormal_hypersensitivity_rea | 2.30283466 |
| 17 | MP0002723_abnormal_immune_serum | 2.30161545 |
| 18 | MP0005025_abnormal_response_to | 2.28997713 |
| 19 | MP0002420_abnormal_adaptive_immunity | 2.25463980 |
| 20 | MP0002452_abnormal_antigen_presenting | 2.25244004 |
| 21 | MP0002419_abnormal_innate_immunity | 2.22624969 |
| 22 | MP0005408_hypopigmentation | 2.22170110 |
| 23 | MP0001819_abnormal_immune_cell | 2.21286115 |
| 24 | MP0002132_abnormal_respiratory_system | 2.09541247 |
| 25 | MP0002138_abnormal_hepatobiliary_system | 1.99537440 |
| 26 | MP0003303_peritoneal_inflammation | 1.97091450 |
| 27 | MP0006082_CNS_inflammation | 1.84651009 |
| 28 | MP0000015_abnormal_ear_pigmentation | 1.82287309 |
| 29 | MP0002166_altered_tumor_susceptibility | 1.77009044 |
| 30 | MP0002398_abnormal_bone_marrow | 1.74734989 |
| 31 | MP0002405_respiratory_system_inflammati | 1.73634716 |
| 32 | MP0003646_muscle_fatigue | 1.71727383 |
| 33 | MP0008004_abnormal_stomach_pH | 1.70951537 |
| 34 | MP0000716_abnormal_immune_system | 1.66122323 |
| 35 | MP0010155_abnormal_intestine_physiology | 1.55261134 |
| 36 | MP0005464_abnormal_platelet_physiology | 1.53162357 |
| 37 | MP0001845_abnormal_inflammatory_respons | 1.53025271 |
| 38 | MP0000371_diluted_coat_color | 1.48334075 |
| 39 | MP0000689_abnormal_spleen_morphology | 1.44015958 |
| 40 | MP0005171_absent_coat_pigmentation | 1.42496218 |
| 41 | MP0002722_abnormal_immune_system | 1.42418790 |
| 42 | MP0003172_abnormal_lysosome_physiology | 1.39550670 |
| 43 | MP0002095_abnormal_skin_pigmentation | 1.39159605 |
| 44 | MP0000703_abnormal_thymus_morphology | 1.38978111 |
| 45 | MP0001533_abnormal_skeleton_physiology | 1.36567448 |
| 46 | MP0002429_abnormal_blood_cell | 1.36198047 |
| 47 | MP0004947_skin_inflammation | 1.34554222 |
| 48 | MP0002006_tumorigenesis | 1.34501071 |
| 49 | MP0009333_abnormal_splenocyte_physiolog | 1.29602964 |
| 50 | MP0003136_yellow_coat_color | 1.26937289 |
| 51 | MP0002102_abnormal_ear_morphology | 1.22793401 |
| 52 | MP0008469_abnormal_protein_level | 1.22338688 |
| 53 | MP0005166_decreased_susceptibility_to | 1.21508026 |
| 54 | MP0005174_abnormal_tail_pigmentation | 1.19168617 |
| 55 | MP0003866_abnormal_defecation | 1.16881893 |
| 56 | MP0005377_hearing/vestibular/ear_phenot | 1.15998545 |
| 57 | MP0003878_abnormal_ear_physiology | 1.15998545 |
| 58 | MP0002277_abnormal_respiratory_mucosa | 1.08434794 |
| 59 | MP0001853_heart_inflammation | 1.08286081 |
| 60 | MP0009764_decreased_sensitivity_to | 1.07324966 |
| 61 | MP0003045_fibrosis | 1.05918231 |
| 62 | MP0003300_gastrointestinal_ulcer | 1.04844154 |
| 63 | MP0006036_abnormal_mitochondrial_physio | 1.03569427 |
| 64 | MP0002396_abnormal_hematopoietic_system | 0.98654757 |
| 65 | MP0001545_abnormal_hematopoietic_system | 0.92147182 |
| 66 | MP0005397_hematopoietic_system_phenotyp | 0.92147182 |
| 67 | MP0001873_stomach_inflammation | 0.90235393 |
| 68 | MP0005310_abnormal_salivary_gland | 0.88373899 |
| 69 | MP0002998_abnormal_bone_remodeling | 0.87285769 |
| 70 | MP0002163_abnormal_gland_morphology | 0.86744939 |
| 71 | MP0000465_gastrointestinal_hemorrhage | 0.86094112 |
| 72 | MP0003656_abnormal_erythrocyte_physiolo | 0.85326135 |
| 73 | MP0001851_eye_inflammation | 0.84616108 |
| 74 | MP0006054_spinal_hemorrhage | 0.83552852 |
| 75 | MP0003786_premature_aging | 0.82455661 |
| 76 | MP0003075_altered_response_to | 0.80958343 |
| 77 | MP0003448_altered_tumor_morphology | 0.78259320 |
| 78 | MP0003828_pulmonary_edema | 0.77319919 |
| 79 | MP0000343_altered_response_to | 0.76427676 |
| 80 | MP0001324_abnormal_eye_pigmentation | 0.75993095 |
| 81 | MP0005058_abnormal_lysosome_morphology | 0.73575637 |
| 82 | MP0004484_altered_response_of | 0.72162825 |
| 83 | MP0009763_increased_sensitivity_to | 0.71874244 |
| 84 | MP0002019_abnormal_tumor_incidence | 0.69139740 |
| 85 | MP0002090_abnormal_vision | 0.66280361 |
| 86 | MP0000858_altered_metastatic_potential | 0.66254771 |
| 87 | MP0002254_reproductive_system_inflammat | 0.64410811 |
| 88 | MP0004808_abnormal_hematopoietic_stem | 0.63312736 |
| 89 | MP0004510_myositis | 0.61646330 |
| 90 | MP0002933_joint_inflammation | 0.60948196 |
| 91 | MP0001764_abnormal_homeostasis | 0.58694243 |
| 92 | MP0003195_calcinosis | 0.58300025 |
| 93 | MP0005319_abnormal_enzyme/_coenzyme | 0.56420682 |
| 94 | MP0005164_abnormal_response_to | 0.55874326 |
| 95 | MP0003950_abnormal_plasma_membrane | 0.55695416 |
| 96 | MP0000678_abnormal_parathyroid_gland | 0.55684538 |
| 97 | MP0001663_abnormal_digestive_system | 0.54045495 |
| 98 | MP0005451_abnormal_body_composition | 0.53076762 |
| 99 | MP0008260_abnormal_autophagy | 0.51739352 |
| 100 | MP0004883_abnormal_blood_vessel | 0.50617784 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Elevated erythrocyte sedimentation rate (HP:0003565) | 4.93796344 |
| 2 | Stomatitis (HP:0010280) | 4.44381110 |
| 3 | T lymphocytopenia (HP:0005403) | 4.19009943 |
| 4 | Abnormality of T cell number (HP:0011839) | 4.08775715 |
| 5 | Ocular albinism (HP:0001107) | 3.99552542 |
| 6 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 3.99038903 |
| 7 | Increased IgM level (HP:0003496) | 3.84308521 |
| 8 | Myositis (HP:0100614) | 3.82095251 |
| 9 | Optic neuritis (HP:0100653) | 3.56504833 |
| 10 | Retrobulbar optic neuritis (HP:0100654) | 3.56504833 |
| 11 | Recurrent bacterial skin infections (HP:0005406) | 3.53855705 |
| 12 | Iris hypopigmentation (HP:0007730) | 3.53109848 |
| 13 | Abnormality of T cells (HP:0002843) | 3.52117720 |
| 14 | Eosinophilia (HP:0001880) | 3.43649232 |
| 15 | Recurrent abscess formation (HP:0002722) | 3.41819899 |
| 16 | Orchitis (HP:0100796) | 3.35437827 |
| 17 | Recurrent cutaneous fungal infections (HP:0011370) | 3.29128125 |
| 18 | Chronic mucocutaneous candidiasis (HP:0002728) | 3.29128125 |
| 19 | Aplasia/Hypoplasia of the macula (HP:0008059) | 3.27431031 |
| 20 | IgM deficiency (HP:0002850) | 3.23531772 |
| 21 | IgG deficiency (HP:0004315) | 3.22455027 |
| 22 | Abnormality of macrophages (HP:0004311) | 3.20603058 |
| 23 | Autoimmune hemolytic anemia (HP:0001890) | 3.14248615 |
| 24 | Granulocytopenia (HP:0001913) | 3.13375351 |
| 25 | Vasculitis (HP:0002633) | 3.07402421 |
| 26 | Recurrent fungal infections (HP:0002841) | 3.07118202 |
| 27 | Recurrent viral infections (HP:0004429) | 3.05721797 |
| 28 | Aplasia/Hypoplasia affecting the retina (HP:0008061) | 3.02456660 |
| 29 | Abnormality of eosinophils (HP:0001879) | 3.01509226 |
| 30 | Gastrointestinal infarctions (HP:0005244) | 3.00852502 |
| 31 | Encephalitis (HP:0002383) | 2.96604720 |
| 32 | Abnormality of T cell physiology (HP:0011840) | 2.91865600 |
| 33 | Meningitis (HP:0001287) | 2.89246897 |
| 34 | Leukocytosis (HP:0001974) | 2.88161178 |
| 35 | Dyschromatopsia (HP:0007641) | 2.88148105 |
| 36 | Recurrent skin infections (HP:0001581) | 2.86795308 |
| 37 | Panhypogammaglobulinemia (HP:0003139) | 2.86587748 |
| 38 | Congenital stationary night blindness (HP:0007642) | 2.77432980 |
| 39 | Abnormality of glycolipid metabolism (HP:0010969) | 2.72553735 |
| 40 | Abnormality of liposaccharide metabolism (HP:0010968) | 2.72553735 |
| 41 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 2.72553735 |
| 42 | Keratoconjunctivitis sicca (HP:0001097) | 2.70364104 |
| 43 | Aplastic anemia (HP:0001915) | 2.66991316 |
| 44 | Absent rod-and cone-mediated responses on ERG (HP:0007688) | 2.65833001 |
| 45 | Pustule (HP:0200039) | 2.63669478 |
| 46 | Pulmonary infiltrates (HP:0002113) | 2.58534156 |
| 47 | Aplasia/Hypoplasia of the fovea (HP:0008060) | 2.58385994 |
| 48 | Hypoplasia of the fovea (HP:0007750) | 2.58385994 |
| 49 | Keratoconjunctivitis (HP:0001096) | 2.54660400 |
| 50 | Mediastinal lymphadenopathy (HP:0100721) | 2.54456295 |
| 51 | Lymphopenia (HP:0001888) | 2.51409745 |
| 52 | Inflammation of the large intestine (HP:0002037) | 2.50411289 |
| 53 | Colitis (HP:0002583) | 2.49442879 |
| 54 | Hemoptysis (HP:0002105) | 2.42716637 |
| 55 | Abnormality of B cell number (HP:0010975) | 2.40137407 |
| 56 | Recurrent bronchitis (HP:0002837) | 2.39580325 |
| 57 | Obstructive lung disease (HP:0006536) | 2.37927128 |
| 58 | Chronic obstructive pulmonary disease (HP:0006510) | 2.37927128 |
| 59 | Petechiae (HP:0000967) | 2.37733732 |
| 60 | Agammaglobulinemia (HP:0004432) | 2.37653603 |
| 61 | Severe combined immunodeficiency (HP:0004430) | 2.35763176 |
| 62 | Eczematoid dermatitis (HP:0000976) | 2.34935438 |
| 63 | Abnormality of cells of the lymphoid lineage (HP:0012140) | 2.34484709 |
| 64 | Gastrointestinal inflammation (HP:0004386) | 2.31555916 |
| 65 | Abnormality of the columella (HP:0009929) | 2.30558472 |
| 66 | Albinism (HP:0001022) | 2.28621651 |
| 67 | Chest pain (HP:0100749) | 2.27050338 |
| 68 | B lymphocytopenia (HP:0010976) | 2.26232170 |
| 69 | Prolonged bleeding time (HP:0003010) | 2.24621847 |
| 70 | Chronic diarrhea (HP:0002028) | 2.23121056 |
| 71 | Generalized hypopigmentation (HP:0007513) | 2.19744389 |
| 72 | Anorexia (HP:0002039) | 2.14948811 |
| 73 | Increased muscle lipid content (HP:0009058) | 2.14401707 |
| 74 | Decreased central vision (HP:0007663) | 2.13356011 |
| 75 | Abnormality of the fovea (HP:0000493) | 2.12032848 |
| 76 | Papilledema (HP:0001085) | 2.11659629 |
| 77 | Thyroiditis (HP:0100646) | 2.10788254 |
| 78 | Autoimmune thrombocytopenia (HP:0001973) | 2.09142667 |
| 79 | Clumsiness (HP:0002312) | 2.08847807 |
| 80 | IgA deficiency (HP:0002720) | 2.07483619 |
| 81 | Gangrene (HP:0100758) | 2.06901302 |
| 82 | Urticaria (HP:0001025) | 2.06844291 |
| 83 | Arterial thrombosis (HP:0004420) | 2.06251626 |
| 84 | Increased intramyocellular lipid droplets (HP:0012240) | 2.01956824 |
| 85 | Renal Fanconi syndrome (HP:0001994) | 2.01567893 |
| 86 | Abnormal rod and cone electroretinograms (HP:0008323) | 2.00442599 |
| 87 | Increased serum ferritin (HP:0003281) | 2.00259895 |
| 88 | Hypergammaglobulinemia (HP:0010702) | 1.98033586 |
| 89 | Cutaneous melanoma (HP:0012056) | 1.95112186 |
| 90 | Recurrent gram-negative bacterial infections (HP:0005420) | 1.92579176 |
| 91 | Spontaneous hematomas (HP:0007420) | 1.89136546 |
| 92 | Chronic otitis media (HP:0000389) | 1.87417563 |
| 93 | Combined immunodeficiency (HP:0005387) | 1.86686840 |
| 94 | Hematochezia (HP:0002573) | 1.86309536 |
| 95 | Recurrent sinusitis (HP:0011108) | 1.85790364 |
| 96 | Hypoproteinemia (HP:0003075) | 1.85161389 |
| 97 | Abnormality of DNA repair (HP:0003254) | 1.83602293 |
| 98 | Lymphoma (HP:0002665) | 1.83344125 |
| 99 | Abnormality of iron homeostasis (HP:0011031) | 1.83052044 |
| 100 | Pulmonary embolism (HP:0002204) | 1.82650983 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MAP4K1 | 5.90216585 |
| 2 | TAOK3 | 3.98538820 |
| 3 | MARK3 | 3.42661400 |
| 4 | TXK | 3.26839193 |
| 5 | EIF2AK3 | 2.40738035 |
| 6 | ZAP70 | 2.37710454 |
| 7 | IKBKE | 2.30054397 |
| 8 | MAP3K14 | 2.23447633 |
| 9 | BLK | 2.07722409 |
| 10 | TYK2 | 2.05291494 |
| 11 | GRK6 | 2.02966870 |
| 12 | RIPK4 | 1.99126062 |
| 13 | MAP3K13 | 1.98598488 |
| 14 | BTK | 1.97228667 |
| 15 | TBK1 | 1.88391876 |
| 16 | NME2 | 1.86273731 |
| 17 | SYK | 1.85807951 |
| 18 | PINK1 | 1.75147055 |
| 19 | IRAK4 | 1.74648805 |
| 20 | TNK2 | 1.69382335 |
| 21 | ITK | 1.67813062 |
| 22 | IKBKB | 1.67160823 |
| 23 | TEC | 1.59613259 |
| 24 | CSK | 1.54223474 |
| 25 | MAP3K5 | 1.54140520 |
| 26 | FGR | 1.48508082 |
| 27 | NLK | 1.42191541 |
| 28 | PRKCQ | 1.39252190 |
| 29 | FES | 1.28959664 |
| 30 | IRAK2 | 1.28902189 |
| 31 | KDR | 1.28536458 |
| 32 | CAMKK2 | 1.22403294 |
| 33 | SCYL2 | 1.19597611 |
| 34 | MAP2K3 | 1.19126593 |
| 35 | FRK | 1.18589895 |
| 36 | KIT | 1.15054921 |
| 37 | HCK | 1.06260878 |
| 38 | ADRBK2 | 1.04168639 |
| 39 | MAP3K1 | 1.02526343 |
| 40 | LCK | 1.01840851 |
| 41 | MAP3K11 | 0.98486379 |
| 42 | LYN | 0.98286223 |
| 43 | CSF1R | 0.97035951 |
| 44 | GRK5 | 0.91354866 |
| 45 | JAK1 | 0.90195420 |
| 46 | JAK3 | 0.85102524 |
| 47 | IRAK1 | 0.84419239 |
| 48 | BMPR2 | 0.84295108 |
| 49 | PDK1 | 0.81714198 |
| 50 | ACVR1B | 0.81067186 |
| 51 | MAP3K3 | 0.79305843 |
| 52 | BMPR1B | 0.77539614 |
| 53 | SIK3 | 0.77092079 |
| 54 | PIM1 | 0.76942241 |
| 55 | TLK1 | 0.76355507 |
| 56 | ADRBK1 | 0.70747066 |
| 57 | GRK7 | 0.69089122 |
| 58 | PRPF4B | 0.66876512 |
| 59 | MATK | 0.66691192 |
| 60 | LRRK2 | 0.66560675 |
| 61 | MYLK | 0.64480029 |
| 62 | PTK2B | 0.64419248 |
| 63 | MELK | 0.64225874 |
| 64 | OBSCN | 0.62129017 |
| 65 | EIF2AK1 | 0.60028139 |
| 66 | STK10 | 0.59888664 |
| 67 | JAK2 | 0.59597148 |
| 68 | TGFBR2 | 0.59497748 |
| 69 | MAPKAPK3 | 0.59412119 |
| 70 | MAP3K12 | 0.57641814 |
| 71 | GRK1 | 0.55295674 |
| 72 | CAMKK1 | 0.53825764 |
| 73 | PIK3CG | 0.50978495 |
| 74 | CLK1 | 0.47065561 |
| 75 | NEK6 | 0.47007327 |
| 76 | CSNK1G3 | 0.45840313 |
| 77 | BRSK2 | 0.45514522 |
| 78 | TAOK2 | 0.44703535 |
| 79 | TIE1 | 0.44359006 |
| 80 | PRKCH | 0.42533345 |
| 81 | NEK2 | 0.40458754 |
| 82 | PDK2 | 0.40056958 |
| 83 | MAPK11 | 0.39996767 |
| 84 | CSNK1A1L | 0.39057383 |
| 85 | STK38L | 0.37629804 |
| 86 | OXSR1 | 0.37422056 |
| 87 | PLK4 | 0.37295866 |
| 88 | EIF2AK2 | 0.36960312 |
| 89 | BCKDK | 0.35466105 |
| 90 | TGFBR1 | 0.32801692 |
| 91 | HIPK2 | 0.31581707 |
| 92 | PDPK1 | 0.30999281 |
| 93 | CHUK | 0.30276276 |
| 94 | MAPK15 | 0.28574184 |
| 95 | CDK3 | 0.26080630 |
| 96 | MAP2K6 | 0.25572093 |
| 97 | WEE1 | 0.25086218 |
| 98 | FGFR3 | 0.23212400 |
| 99 | CSNK1G1 | 0.22834243 |
| 100 | PRKG2 | 0.22050680 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Primary immunodeficiency_Homo sapiens_hsa05340 | 4.39590330 |
| 2 | Allograft rejection_Homo sapiens_hsa05330 | 3.78041919 |
| 3 | Graft-versus-host disease_Homo sapiens_hsa05332 | 3.54935807 |
| 4 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 3.47181495 |
| 5 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 2.90609408 |
| 6 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 2.75162799 |
| 7 | Antigen processing and presentation_Homo sapiens_hsa04612 | 2.65143196 |
| 8 | Asthma_Homo sapiens_hsa05310 | 2.57853186 |
| 9 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 2.54971946 |
| 10 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 2.46675456 |
| 11 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 2.37114674 |
| 12 | Leishmaniasis_Homo sapiens_hsa05140 | 2.35209057 |
| 13 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 2.32385097 |
| 14 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 2.25547771 |
| 15 | Osteoclast differentiation_Homo sapiens_hsa04380 | 2.19018990 |
| 16 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 2.10621079 |
| 17 | Measles_Homo sapiens_hsa05162 | 1.91405005 |
| 18 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.90613250 |
| 19 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.83627044 |
| 20 | Viral myocarditis_Homo sapiens_hsa05416 | 1.75388606 |
| 21 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 1.73229538 |
| 22 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 1.71901312 |
| 23 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.64032824 |
| 24 | Legionellosis_Homo sapiens_hsa05134 | 1.62756232 |
| 25 | Malaria_Homo sapiens_hsa05144 | 1.62332593 |
| 26 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 1.55694003 |
| 27 | Tuberculosis_Homo sapiens_hsa05152 | 1.55444750 |
| 28 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 1.54587609 |
| 29 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.50799906 |
| 30 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 1.47000330 |
| 31 | Proteasome_Homo sapiens_hsa03050 | 1.45243140 |
| 32 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 1.37232587 |
| 33 | Influenza A_Homo sapiens_hsa05164 | 1.32236680 |
| 34 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 1.23926678 |
| 35 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.22026918 |
| 36 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.17938748 |
| 37 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.17625187 |
| 38 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 1.01903345 |
| 39 | Pertussis_Homo sapiens_hsa05133 | 0.98149193 |
| 40 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.93773584 |
| 41 | Phototransduction_Homo sapiens_hsa04744 | 0.89774432 |
| 42 | Apoptosis_Homo sapiens_hsa04210 | 0.89361586 |
| 43 | Phagosome_Homo sapiens_hsa04145 | 0.86873925 |
| 44 | Hepatitis B_Homo sapiens_hsa05161 | 0.85310015 |
| 45 | Olfactory transduction_Homo sapiens_hsa04740 | 0.82766103 |
| 46 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.81577348 |
| 47 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.77946450 |
| 48 | Ribosome_Homo sapiens_hsa03010 | 0.77915512 |
| 49 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.76049938 |
| 50 | Other glycan degradation_Homo sapiens_hsa00511 | 0.74701813 |
| 51 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.73487660 |
| 52 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.71602190 |
| 53 | Hepatitis C_Homo sapiens_hsa05160 | 0.64894440 |
| 54 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.63483482 |
| 55 | Lysosome_Homo sapiens_hsa04142 | 0.63443919 |
| 56 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.61921133 |
| 57 | Platelet activation_Homo sapiens_hsa04611 | 0.61769469 |
| 58 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.60067999 |
| 59 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.55344966 |
| 60 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.53100946 |
| 61 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.51283481 |
| 62 | HTLV-I infection_Homo sapiens_hsa05166 | 0.50394967 |
| 63 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.48596086 |
| 64 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.48175376 |
| 65 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.47942614 |
| 66 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 0.46588278 |
| 67 | Shigellosis_Homo sapiens_hsa05131 | 0.46156770 |
| 68 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.40419358 |
| 69 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.40131548 |
| 70 | RNA degradation_Homo sapiens_hsa03018 | 0.40045103 |
| 71 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.38024270 |
| 72 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.37865026 |
| 73 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.36097924 |
| 74 | Purine metabolism_Homo sapiens_hsa00230 | 0.34828189 |
| 75 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.34751474 |
| 76 | Homologous recombination_Homo sapiens_hsa03440 | 0.32390070 |
| 77 | Basal transcription factors_Homo sapiens_hsa03022 | 0.31498512 |
| 78 | Parkinsons disease_Homo sapiens_hsa05012 | 0.29954090 |
| 79 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.29754191 |
| 80 | Nitrogen metabolism_Homo sapiens_hsa00910 | 0.28233707 |
| 81 | RNA polymerase_Homo sapiens_hsa03020 | 0.25983029 |
| 82 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.25452710 |
| 83 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.24779064 |
| 84 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.24175678 |
| 85 | Salmonella infection_Homo sapiens_hsa05132 | 0.24032928 |
| 86 | p53 signaling pathway_Homo sapiens_hsa04115 | 0.24030101 |
| 87 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 0.22630678 |
| 88 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.22390911 |
| 89 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.22326618 |
| 90 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 0.22096738 |
| 91 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 0.21946557 |
| 92 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.20187430 |
| 93 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.19237068 |
| 94 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.18909233 |
| 95 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 0.18529399 |
| 96 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.18195313 |
| 97 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.14332391 |
| 98 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.12335894 |
| 99 | Mineral absorption_Homo sapiens_hsa04978 | 0.12066952 |
| 100 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.10464492 |

